SLAMF9 antibody is predicted to not cross-react with other SLAM protein family members.
Purification
SLAMF9 Antibody is affinity chromatography purified via peptide column.
Immunogène
SLAMF9 antibody was raised against a 19 amino acid synthetic peptide near the carboxy terminus of human SLAMF9. The immunogen is located within the last 50 amino acids of SLAMF9.
SLAMF9
Reactivité: Humain
WB, EIA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
SLAMF9 antibody can be used for detection of SLAMF9 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in mouse samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
SLAMF9 Antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
SLAMF9 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
anticorps CD2F-10, anticorps CD2F10, anticorps CD84-H1, anticorps CD84H1, anticorps SF2001, anticorps 2310026I04Rik, anticorps AI462096, anticorps Cd2f10, anticorps SLAM family member 9, anticorps SLAMF9, anticorps Slamf9
Sujet
SLAMF9 Antibody: The SLAM (signalling lymphocyte activation molecule) family is a novel group of receptors on T cells in modulating the immune response. SLAMF9, also known as CD2F-10 or CD84 homolog, is a 289 amino acid type I transmembrane protein that shares 58 % identity with the mouse protein. The SLAMF9 protein is predominantly expressed in hematopoietic tissues and contains an extracellular region with only two N-linked glycosylation sites, a 20-residue transmembrane region and a highly positively charged 30-residue cytoplasmic tail, suggesting a role for SLAMF9 as an adhesion molecule. SLAMF9 is thought to function in the immune response as a coreceptor for lymphocyte activation.